CSIMarket


Orgenesis Inc   (ORGS)
Other Ticker:  
 

Orgenesis Inc

ORGS's Fundamental analysis








Orgenesis Inc 's sales fell by -0.7 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 3388

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.34 %

Orgenesis Inc 's net profit deacreased by -57.2 % in I. Quarter 2024 year on year, to $10 millions.

More on ORGS's Growth


Orgenesis Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Orgenesis Inc PEG ratio is at 0.02 Orgenesis Inc realized cash outflow of $ -0.1per share in trailing twelve-month period.
Company
0.38
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.


More on ORGS's Valuation
 
 Total Debt (Millions $) 24
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -389,023,748
 Net Income/Employee (TTM) $ 560,523
 Receivable Turnover (TTM) -421284.25
 Tangible Book Value (Per Share $) -1.14

Orgenesis Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Orgenesis Inc PEG ratio is at 0.02 Orgenesis Inc realized cash outflow of $ -0.1per share in trailing twelve-month period.
Company
0.38
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.45.


More on ORGS's Valuation

  Market Capitalization (Millions $) 19
  Shares Outstanding (Millions) 33
  Employees 111
  Revenues (TTM) (Millions $) -43,182
  Net Income (TTM) (Millions $) 62
  Cash Flow (TTM) (Millions $) -3
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) 24
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -389,023,748
  Net Income/Employee(TTM) $ 560,523
  Receivable Turnover Ratio (TTM) -421284.25
  Tangible Book Value (Per Share $) -1.14

  Market Capitalization (Millions $) 19
  Shares Outstanding (Millions) 33
  Employees 111
  Revenues (TTM) (Millions $) -43,182
  Net Income (TTM) (Millions $) 62
  Cash Flow (TTM) (Millions $) -3
  Capital Exp. (TTM) (Millions $) -1


    ORGS's Profitability Comparisons
Orgenesis Inc achieved increase in profitability, due to cost pressure. Operating Margin grew in I. Quarter 2024 to 6333.33 %.

Orgenesis Inc net profit margin of 7095.74 % is currently ranking no. 1 in Major Pharmaceutical Preparations industry, ranking no. 1 in Healthcare sector and number 13 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 0.07
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) -2103.19
  Inventory Turnover Ratio (TTM) 1269968.68



Orgenesis Inc achieved increase in profitability, due to cost pressure. Operating Margin grew in I. Quarter 2024 to 6333.33 %.

Orgenesis Inc net profit margin of 7095.74 % is currently ranking no. 1 in Major Pharmaceutical Preparations industry, ranking no. 1 in Healthcare sector and number 13 in S&P 500.

More on ORGS's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com